Sustainability resources
Home / Sustainability / Sustainability resources
How we contribute to a more sustainable future
Our commitment to operating a responsible, resilient and sustainable business is reflected in how we manage sustainability-related impacts, risks, and opportunities as outlined in the following resources.
Any prior statements should be considered historical and no longer indicative of our forward plans.
Sustainability reporting
2025
2024
2023
Environment
Social
Governance
Ratings
We contribute to key global environmental, social and governance (ESG) performance evaluations and recognise the value of independent third-party assessment and insights.
Our 2025 performance:
Rating |
Score |
Status |
|---|---|---|
Sustainalytics |
18.3 |
Low risk |
MSCI |
A |
Reflects above‑average management risks relative to industry peers |
CDP
|
A A- B- |
Achieved CDP leadership scores for over a decade for Climate (A) and Water Security (A-), in recognition of the actions taken to cut emissions, mitigate climate risks, engage our supply chain, and deliver on water stewardship |
CSA |
75/100 |
S&P Sustainability Yearbook Member |
EcoVadis |
Gold |
Maintained Gold status for the third consecutive year running in recognition of sustainability efforts in environment, labour and human rights, ethics, and sustainable procurement |
Access to Medicine Index (ATMi) |
5th/ 20 |
Ranked as top five for providing access to medicines to people in low and middle income countries |
ISS ESG |
B |
Indicates good performance of management of ESG risks |
Recognitions
2025 Recognitions
TIME Magazine
In 2026, we were recognised among TIME’s World's Most Sustainable Companies for the third consecutive year and among the top three in pharma. This builds on the triple TIME Magazine recognitions World's Most Sustainable Companies, World's Best Companies in Sustainable Growth and World's Best Companies achieved in 2025 and 2024.
Newsweek’s World’s Greenest Companies
In 2025 and 2026, Newsweek recognised AstraZeneca as one of the World’s Greenest Companies, awarding the highest 5-star rating for environmental stewardship.
Sustainability Magazine
Secured a top five ranking in Sustainability Magazine’s Top 250 Companies in Sustainability. In addition, Pam Cheng, our Chief Sustainability Officer, was among the top 5 Top 250 Sustainability Leaders, which recognises those driving impact on sustainability.
Financial Times’ ‘Europe’s Climate Leaders’
For the sixth year running, listed as a European Climate Leader, also ranked first among pharmaceutical companies, based on total reduction of core Scope 1 and 2 greenhouse gas emissions and emissions intensity over a five-year period (2019-2024 for the 2026 list), as well as climate-related commitments.
Forbes World’s Top Companies for Women
Listed as one of 400 World's Top Companies for Women
Policies and standards
Code of Ethics
Our Code of Ethics defines our values at work and guides everything we do, ensuring that we deliver life-changing medicines in a responsible way.
